The launch highlights the growing maturity of India's nuclear medicine ecosystem.
Mercedes-Benz India is exploring a larger role for plug-in hybrid electric vehicles (PHEVs) in its portfolio, with plans to potentially introduce the technology in more models beyond the newly launched S-Class plug-in hybrid. This strategy aims to cater to luxury car buyers who are hesitant about fully electric vehicles due to concerns over charging infrastructure and range.
Mahindra & Mahindra (M&M) is expanding its farm equipment strategy beyond tractors to include a wider range of mechanisation solutions like harvesters, balers, seed drills, and telematics-enabled services, aiming to capitalise on the growing demand for rental services by rural entrepreneurs and address low mechanisation levels in Indian agriculture.
Companies are already diversifying sourcing, raising prices, and reworking operating models as the disruption drags on.
Tata Motors' commercial vehicle business is increasingly focusing on parts, services, connected-vehicle platforms, and digital businesses to drive growth and reduce dependence on cyclical vehicle sales, as outlined in its FY26 annual report.
Indian pharmaceutical companies are strategically increasing investments in the US market, focusing on specialty drugs, complex generics, respiratory products, and local manufacturing, despite a nearly 10 per cent fall in exports to the US in FY26 due to pricing pressure and competition in traditional generics.
While SUVs have steadily gained share across the industry, data shows that nearly three in 10 luxury vehicles sold in India are sedans, highlighting the segment's resilience despite years of SUV-led growth.
Maruti Suzuki India reported a significant 147 per cent year-on-year increase in mini-car sales (Alto and S-Presso) during April-May 2026, reaching 32,341 units, driven by eased production constraints and a surge in demand for CNG vehicles amidst rising fuel prices.
'Leadership is about understanding how a business works, how it is shaped, built, and expanded.'
India's leading passenger vehicle manufacturers are significantly increasing investments and factory capacities, alongside planning major product launches for FY27, driven by strong confidence in sustained domestic demand growth despite global geopolitical tensions and supply chain risks.
Tata Motors' MD and CEO, Girish Wagh, has identified rising diesel prices as the most significant threat to India's commercial vehicle (CV) industry recovery, despite the sector recently surpassing its pre-FY19 wholesale peak. Diesel costs account for 25-50% of a truck operator's total cost of ownership, making any increase a critical concern for fleet economics.
Biocon is actively seeking in-licensing opportunities to expand its biosimilars portfolio, focusing on products that complement existing therapy areas, as the company shifts to a 'consolidate' phase with a strong emphasis on improving capacity utilisation, expanding margins, and driving return on capital employed.
Bajaj Auto is set to launch new Pulsar motorcycles in the 125cc and 150-250cc segments in Q2 FY27, aiming to capitalise on the upcoming festival season surge. This move follows strong growth in the 150cc-plus segment, where refreshed Pulsar models already account for over 50 per cent of Bajaj's sales.
Mahindra & Mahindra (M&M) is implementing a comprehensive, multi-layered strategy to fortify its supply chains against geopolitical volatility, logistical challenges, and regulatory risks, drawing lessons from recent global disruptions.
Bajaj Auto reported a significant increase in its consolidated Q4FY26 performance, with profit after tax more than doubling to approximately 3,662 crore, a 103 per cent year-on-year rise, primarily driven by record volumes, an improved product mix, and the strategic consolidation of Bajaj Auto International Holdings AG (BAIHAG).
Kiran Mazumdar-Shaw names niece Claire Mazumdar as successor at Biocon. Explore the leadership transition, strategy, and future plans.
India's pharmaceutical industry is experiencing increased bulk drug prices, particularly for APIs from China, following the escalation of the West Asia crisis in March. While current inventories provide a temporary buffer, concerns are mounting over the availability of key solvents and feedstocks, potentially leading to manufacturing disruptions and shortages in specific drug categories.
Maruti Suzuki has discontinued its Ignis hatchback due to weak sales and a shift towards SUVs, while simultaneously facing supply chain issues for its popular S-Presso and WagonR models, leading to booking halts at some dealerships.
India's electric passenger vehicle market saw an 87.4 per cent year-on-year increase in FY26, reaching 233,246 units, primarily driven by the mid-size SUV segment (20-30 lakh price bracket), while the entry-level segment (sub-10 lakh) experienced a decline.
koda Auto Volkswagen India aims to capture a 5 per cent share of India's passenger vehicle market by 2030, driven by new product launches, including alternate fuel vehicles, and a potential entry into the high-volume sub-4 metre SUV segment.
